Leidos Secures Defense Agreement to Enhance Military Capabilities
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 52 minutes ago
0mins
Should l Buy LDOS?
Source: PRnewswire
- Defense Agreement Signed: Leidos has secured a framework agreement with the Department of Defense to deliver an initial 3,000 Low-Cost Containerized Munitions (LCCM), significantly enhancing the U.S. ground-launched combat capabilities and showcasing Leidos' ability to rapidly scale defense production.
- Production Capacity Expansion: The company plans to expand its facilities in Huntsville, Alabama, and McEwen, Tennessee, with production of the LCCM expected to begin in 2027, reflecting Leidos' commitment to advancing operational capabilities through strategic investments.
- Technological Innovation: The LCCM design builds on the AGM-190A Small Cruise Missile, featuring a modular airframe and a common Weapon Open Systems Architecture (WOSA), which not only increases mission effectiveness and fuel capacity but also supports rapid integration and upgrades, enhancing mission adaptability.
- Future Development Strategy: Leidos' NorthStar 2030 strategy emphasizes responding to the Department of Defense's need for rapid procurement of critical capabilities through self-funded development and expanded production capabilities, further solidifying its leadership in advanced missile system design and integration.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LDOS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LDOS
Wall Street analysts forecast LDOS stock price to rise
11 Analyst Rating
7 Buy
4 Hold
0 Sell
Moderate Buy
Current: 128.390
Low
178.00
Averages
219.70
High
235.00
Current: 128.390
Low
178.00
Averages
219.70
High
235.00
About LDOS
Leidos Holdings, Inc. is a holding company, which operates through its wholly owned subsidiary, Leidos, Inc. (Leidos). The Company's segments include National Security & Digital, Health & Civil, Commercial & International and Defense Systems. Its National Security & Digital business provides technologically advanced services, solutions and products, as well as mission software capabilities for defense and intelligence customers in the areas of cyber, logistics, security operations and decision analytics. Its Health & Civil business provides services and solutions to federal and commercial customers in the areas of public health, care coordination, life and environmental sciences and transportation. Its Commercial & International business delivers a portfolio of products, services, and solutions aimed at securing national assets, modernizing energy and critical infrastructure, and enhancing mission outcomes. The Company serves government and commercial customers.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Significant Contract Value: Leidos has been awarded a $2.7 billion contract by the U.S. Army to advance hypersonic weapons from prototyping to production, which is expected to significantly enhance the company's market position and revenue potential.
- Program Integration: This contract unifies the Thermal Protection Shield (TPS) and Common Hypersonic Glide Body (CHGB) programs, aiming to accelerate development and delivery in alignment with Army acquisition reform initiatives, thereby improving operational efficiency.
- Technological Expertise: Leidos leverages its proven expertise in guidance systems, sensor technologies, and precision munitions integration to enhance the nation's hypersonic capabilities and strengthen integrated air and missile defense, ensuring readiness for future military demands.
- Strategic Alignment: The contract aligns with Leidos' NorthStar 2030 strategy, emphasizing the company's commitment to innovation and technological leadership in defense and national security, thereby securing its competitive edge in future military capabilities.
See More
- Contract Scale: Leidos has signed a framework agreement with the Department of War to deliver an initial 3,000 Low-Cost Containerized Munitions (LCCM), which is expected to significantly enhance the U.S. ground-launched combat capabilities, showcasing Leidos' ability to rapidly scale defense production.
- Production Capacity Expansion: The company will expand its facilities in Huntsville, Alabama, and McEwen, Tennessee, to support LCCM production, with production expected to begin in 2027, reflecting Leidos' commitment to advancing operational capabilities.
- Technological Innovation: The LCCM design builds on the AGM-190A Small Cruise Missile, featuring a modular airframe and a common Weapon Open Systems Architecture (WOSA) that enables rapid integration and mission adaptability, enhancing mission effectiveness and fuel capacity.
- Strategic Implications: Leidos' decision to fund development and expand production capabilities aligns with its NorthStar 2030 strategy, demonstrating the company's leadership in advanced missile system design and integration, thereby reinforcing its technological trust with the U.S. military.
See More
- Defense Agreement Signed: Leidos has secured a framework agreement with the Department of Defense to deliver an initial 3,000 Low-Cost Containerized Munitions (LCCM), significantly enhancing the U.S. ground-launched combat capabilities and showcasing Leidos' ability to rapidly scale defense production.
- Production Capacity Expansion: The company plans to expand its facilities in Huntsville, Alabama, and McEwen, Tennessee, with production of the LCCM expected to begin in 2027, reflecting Leidos' commitment to advancing operational capabilities through strategic investments.
- Technological Innovation: The LCCM design builds on the AGM-190A Small Cruise Missile, featuring a modular airframe and a common Weapon Open Systems Architecture (WOSA), which not only increases mission effectiveness and fuel capacity but also supports rapid integration and upgrades, enhancing mission adaptability.
- Future Development Strategy: Leidos' NorthStar 2030 strategy emphasizes responding to the Department of Defense's need for rapid procurement of critical capabilities through self-funded development and expanded production capabilities, further solidifying its leadership in advanced missile system design and integration.
See More
- Low-Cost Missile Procurement: The Pentagon is set to launch the Low-Cost Containerized Munitions (LCCM) program in 2027, aiming to acquire over 10,000 low-cost missiles over three years, reflecting a strategic shift towards innovative defense technologies to enhance military deployment flexibility and cost-effectiveness.
- Test Missile Acquisition: The assessment phase of the program will begin in June 2026, involving the purchase of test missiles from Anduril, CoAspire, Leidos, and Zone 5, establishing terms for future firm-fixed-price production contracts, which indicates strong support for emerging contractors by the Pentagon.
- Blackbeard Missile Contract: A separate agreement with defense startup Castelion outlines a plan for a two-year contract to purchase a minimum of 500 Blackbeard missiles once testing and validation are completed, highlighting the Pentagon's focus on hypersonic weapons, with plans to acquire over 12,000 missiles in five years.
- Increased Funding Demand: The Pentagon is ramping up requests to Congress for over $26 billion in funding for multi-year procurement contracts for critical munitions, emphasizing the urgency and significance of military equipment in response to ongoing demands from the war in Iran.
See More
- Significant Contract Value: The U.S. Army has awarded Leidos Holdings a $2.7 billion contract aimed at advancing hypersonic weapons from prototype development to production, highlighting the strategic importance of hypersonic technology in the arms race.
- Technological Integration Benefits: This deal combines Leidos' Thermal Protection Shield program, which protects hypersonic weapons from extreme heat and pressure during flight, with its Common Hypersonic Glide Body program responsible for the body of the long-range hypersonic missile named 'Dark Eagle'.
- Production Efficiency Gains: By integrating these two programs, Leidos stated it would help reduce production timelines and ensure a reliable supply of components to meet increasing operational demands, thereby enhancing the company's competitive position in the defense sector.
- Far-reaching Strategic Implications: Hypersonic weapons are central to the U.S.-China arms race, and this contract not only strengthens Leidos' position in the defense industry but may also drive further development and application of related technologies.
See More
- Significant Contract Value: Leidos has been awarded a $2.7 billion U.S. Army contract aimed at advancing hypersonic weapons from prototyping to production, showcasing the company's robust capabilities in the defense sector.
- Efficiency Through Integration: This contract unifies the Thermal Protection Shield (TPS) and Common Hypersonic Glide Body (CHGB) programs to accelerate development and delivery, aligning with Army acquisition reform initiatives to enhance operational efficiency.
- Technological Leadership: Leidos' expertise in guidance systems, sensor technologies, and precision munitions integration will bolster the nation's hypersonic capabilities and strengthen integrated air and missile defense, ensuring operational demands are met.
- Strategic Alignment for the Future: The contract aligns with Leidos' NorthStar 2030 strategy, emphasizing a commitment to innovation in defense and national security, positioning the company to establish future military capabilities as a key pillar of its long-term corporate vision.
See More







